Trial intelligence / Profile preview

Oxytocin in the Second Stage of Labor (ROSSoL)

NCT04303702Recruiting

Sponsor
Washington University School of Medicine
Start
Jul 2022
Primary completion
Jun 2027
Modality
Peptides
Countries
1
01

Overview

Randomised, open-label trial of oxytocin, sponsored by Washington University School of Medicine. Primary endpoint: Second stage duration. Started Jul 2022; status: recruiting.

02

Drugs

oxytocin

Beyond the preview

Go deeper on NCT04303702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04303702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call